Rocket Lab CFO Sells $18.7M as Neutron Slips to 2027
Rocket Lab's CFO and four executives sold $26.96 million in stock over 90 days at prices from $62 to $72, all above the $52.60 where shares now trade following a 25% monthly decline triggered by Neutr
Rocket Lab CFO Sells $18.7M as Neutron Slips to 2027
NEW YORK, October 26 —
Even as Wall Street's $102.15 consensus price target implies 94% upside on Rocket Lab Corporation (RKLB), the company's CFO and four colleagues sold $26.96 million in stock over 90 days at $62, $72, all above the $52.60 at which RKLB now trades after manufacturing issues pushed Neutron's first flight to 2027 and shares shed 25% in a month.
- CFO Adam Spice sold 280,314 shares at $62, $72, netting ~$18.7M after $1.09 option exercises; all above current $52.60
- Five executives sold $26.96M net over 90 days; zero open-market purchases; sellers include CFO, COO, and General Counsel
- $2.36B backlog, 137% YoY growth; Neutron first flight slips to 2027; trailing FCF -$252M
The Selling Pattern
CFO Adam Spice ran the same trade twice in six weeks: exercise 140,157 options at $1.09 per share, then sell the entire block the same day. On September 2, those shares cleared $62.26, $62.97 for open-market proceeds of $8.78 million. On October 1, the same block sold at $70.28, $71.79 for $9.93 million more. Six days before the second sale, COO Frank Klein, General Counsel Arjun Kampani, VP Controller Agostino Ricupati, and President Marvin Bradford Clevenger also sold in coordinated open-market transactions at $69.53, $71.17. Three days after the August 10 earnings release, Rocket Lab filed a 424B5 prospectus supplement with the SEC. The 90-day tally: $26.96 million out, nothing in.
Backlog Versus Burn
Rocket Lab's Electron orbital launch vehicle and Space Systems segment, which builds satellites and spacecraft components, posted $0.77 billion in trailing revenue with 62% year-over-year growth and a $2.36 billion backlog anchored by an $816 million Space Development Agency contract. The key catalyst is Neutron, a medium-class reusable rocket targeting large constellation and interplanetary missions, and Neutron just slipped to 2027 after a forward propellant dome manufacturing defect emerged, triggering a 14% single-session decline. With $2.30 billion in cash against $0.13 billion in debt, Rocket Lab has runway; the question is whether -$252 million in free cash flow validates the multiple while Neutron waits.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| RKLB | $33.6B | 914.9x | -19.8% |
| ASTS | $15.5B | n/a | -49.9% |
| NBIS | $40.3B | n/a | +26.6% |
| IONQ | $13.4B | n/a | -50.2% |
| IREN | $10.1B | n/a | -61.7% |
| CRWV | $29.9B | n/a | -60.1% |
The Number That Changes the Thesis
The bull case, backed by 16 of 20 analysts at Buy, a $2.36 billion backlog up 137%, and an $816 million government contract, survives if Neutron delivers in 2027. But the most recent quarter broke a three-beat EPS streak, and every executive in the disclosure chain sold above the $52.60 that the Neutron delay ultimately produced. The metric to watch is Neutron's propellant dome resolution: a credible build milestone before year-end reopens the backlog narrative; another slip does not. Stress-test the scenarios in the DCF calculator, or run the free Rocket Lab Corporation deep-dive → to track when the fundamentals shift.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why did Rocket Lab's CFO sell stock?
CFO Adam Spice sold 280,314 shares at prices from $62 to $72 per share, netting approximately $18.7 million after option exercises. The sales occurred in two coordinated tranches in September and October, with five executives collectively selling $26.96 million in stock over 90 days.
What happened to Rocket Lab's Neutron rocket?
Neutron's first flight slipped to 2027 following a forward propellant dome manufacturing defect, triggering a 14% single-session stock decline. With trailing free cash flow of negative $252 million, the question becomes whether the company's fundamentals justify its valuation while awaiting Neutron's delayed launch.
Where does Rocket Lab stock trade now?
Shares now trade at $52.60 after shedding 25% in a month, down from the $62 to $72 prices at which executives sold their stock. Wall Street's $102.15 consensus price target implies 94% upside from current levels.
What is Rocket Lab's financial runway?
The company holds $2.30 billion in cash against $0.13 billion in debt, providing substantial runway. However, the company burned $252 million in free cash flow over the trailing 12 months.
What is driving the bull case for Rocket Lab?
Sixteen of twenty analysts rate the stock as Buy, citing the $2.36 billion backlog with 137% year-over-year growth and an $816 million Space Development Agency contract. The bull case depends on Neutron delivering as promised in 2027.
Rocket Lab CFO Adam Spice sold approximately $18.7 million in stock between August and October 2026 at prices ranging from $62 to $72 per share — every insider sale now sits above the current market price of $52.60, which has declined roughly 25% in a month after manufacturing issues pushed the Neutron launch vehicle's first flight to 2027. Wall Street's consensus price target of $102.15 simultaneously implies 94% upside.